Supplementary Figures 1 - 9 from Small Molecule Agonists of PPAR-γ Exert Therapeutic Effects in Esophageal Cancer

PDF file - 818K, The study design for selecting the ESCC patients (S1); TE-4 cells were transfected with PPARG siRNA (S2); In vitro anti-proliferative effects of efatutazone (S3); Anti-proliferative effects of efatutazone in ESCC cells occur via pAkt-p21Cip1 (S4); In vivo anti-proliferative effects of efatutazone (S5); Investigation using condition medium (S6); EGFR/MAPK signaling activation (S7); Anti-proliferative effects of molecule targeted therapy (S8); The primers and probes used for real time RT-PCR (S9).